Charles A. Powell, MD, Named Chief of the Division of Pulmonary, Critical Care and Sleep Medicine

Dr. Powell’s collaborative translational research in lung cancer has helped lead to the recategorization of the disease.

New York, NY
 – March 30, 2011 /Press Release/  –– 

Charles A. Powell, MD, will join The Mount Sinai Medical Center in New York as Chief of the Catherine and Henry J. Gaisman Division of Pulmonary, Critical Care and Sleep Medicine. The appointment takes effect July 2011.

Dr. Powell comes to Mount Sinai from Columbia University Medical Center, where he was Associate Professor of Medicine and Associate Division Chief of the Division of Pulmonary, Allergy, and Critical Care Medicine. He was also Director of the Pulmonary and Critical Care Medicine Fellowship and Medical Director for the High Risk Lung Assessment Program at New York Presbyterian Hospital. His collaborative translational research in lung cancer has helped lead to the recategorization of this disease.

"Mount Sinai’s division of Pulmonary, Critical Care, and Sleep Medicine has a strong foundation for Dr. Powell to build upon," said Mark Babyatsky, MD, Professor and Chair of the Samuel Bronfman Department of Medicine, Mount Sinai School of Medicine. "We advanced the treatment of tuberculosis, introduced the use of oxygen tanks to the inpatient setting, and after establishing one of the first sarcoidosis clinics in the nation, we remain one of the leading centers for the treatment of this condition in the U.S." The critical care clerkship is also the highest ranked among fourth-year medical students at Mount Sinai.

Dr. Powell completed his medical degree at University of Chicago Pritzker School of Medicine, his residency at Columbia Presbyterian Medical Center, and his clinical and research fellowships at Boston University School of Medicine.

With clinical and research interests in lung cancer and mesothelioma, Dr. Powell’s investigations center on understanding the genetic and susceptibility factors for these diseases, and the molecular events that are important in the early stages of lung cancer development and progression. His numerous articles and abstracts have been published in journals such as the American Journal of Respiratory and Critical Care Medicine, American Journal of Pathology, CHEST, Cancer, and the American Journal of Respiratory Cell and Molecular Biology. He is Chair of the Thoracic Oncology Section of the American Thoracic Society, an elected member of the Fleischner Society, and a recipient of the American Cancer Society Research Scholar Award.

"Dr. Powell will advance our multidisciplinary lung cancer center of excellence by furthering our strengths in cardiothoracic surgery, radiology, and radiation oncology," said Steven J. Burakoff, M.D., Director of The Tisch Cancer Institute. "Continued progress in these areas is vital to the missions of The Tisch Cancer Institute."

About The Mount Sinai Medical Center

The Mount Sinai Medical Center encompasses both The Mount Sinai Hospital and Mount Sinai School of Medicine. Established in 1968, Mount Sinai School of Medicine is one of few medical schools embedded in a hospital in the United States. It has more than 3,400 faculty in 32 departments and 15 institutes, and ranks among the top 20 medical schools both in National Institute of Health funding and by U.S. News & World Report. The school received the 2009 Spencer Foreman Award for Outstanding Community Service from the Association of American Medical Colleges.

The Mount Sinai Hospital, founded in 1852, is a 1,171-bed tertiary- and quaternary-care teaching facility and one of the nation's oldest, largest and most-respected voluntary hospitals. U.S. News & World Report consistently ranks The Mount Sinai Hospital among the nation's best hospitals based on reputation, patient safety, and other patient-care factors. Nearly 60,000 people were treated at Mount Sinai as inpatients last year, and approximately 530,000 outpatient visits took place.

For more information, visit
Find Mount Sinai on:
Twitter @mountsinainyc